ASP-2246

N/A

Report date: 2026/04/16 20:00:17

Base Information

Drug NameASP-2246
Drug Alias NameASP2246ASP-2246
ClassificationCell and gene therapy > Gene therapy > mRNACell and gene therapy > Gene therapy > LNP
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsIschemic Stroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAstellas Pharma Inc
Inactive CompaniesN/A
Active IndicationsIschemic Stroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A